Revance Therapeutics Inc.
| Year | Mar | Jun | Sep | Dec | Annual | |
|---|---|---|---|---|---|---|
| 2023 | -0.74 | -0.80 | -1.63 | - | - | |
| 2022 | -0.94 | -0.88 | -1.17 | -1.91 | -4.9 | |
| 2021 | -1.08 | -1.07 | -1.1 | -0.92 | -4.17 | |
| 2020 | -1.15 | -1.12 | -1.34 | -1.25 | -4.86 | |
| 2019 | -0.85 | -0.86 | -0.96 | -1 | -3.67 | |
| 2018 | -0.97 | -0.94 | -0.91 | -1.12 | -3.94 | |
| 2017 | 0.94 | 0.90 | 1.01 | 1.14 | 3.99 | |
| 2016 | 0.71 | 0.88 | 0.64 | 0.95 | 3.18 | |
| 2015 | 0.65 | 0.71 | 0.81 | 0.83 | 3 | |
| 2014 | -1.93 | -0.69 | -0.60 | -0.02 | -3.24 | |
| 2013 | 21.00 | -75.25 | -55.92 | -47.11 | 1.05 | |
| 2012 | - | - | - | 0.00 | -290.48 | |
| 2011 | - | - | - | 0.00 | -226.06 |